Programme and Presentations
UK & Ireland Prostate Brachytherapy Conference 2026
Tips and Tricks in Brachytherapy
Watford Football Club, Vicarage Road Stadium, Watford
| 08:30 | Welcome & Opening – the history of Mount Vernon Cancer Centre | Peter Hoskin & Andreas Makris Mount Vernon Cancer Centre |
| Invited Speakers | Chairs: Mohammed Abdul‑Latif, Thomas Hague & Dan Meigas |
|
| 09:00 | Tips and Tricks – Physician’s perspective | Roberto Alonzi Mount Vernon Cancer Centre |
| 09:25 | Tips and Tricks – Physicist’s perspective. Sharper Plans and Greener Practice – optimiser tips & seeking long-term sustainability in Brachytherapy | George Kirby & Gerry Lowe Mount Vernon Cancer Centre |
| 09:50 | Tips and Tricks – Radiographer’s perspective | RTT Team Mount Vernon Cancer Centre |
| 10:20 | One-minute Poster Pitches | |
| 10:45 | Tea & Coffee/Exhibition and Poster Viewing | |
| 11.15 | Prostate Guideway – Redefining confidence in the Interventional Suite | Elekta |
| Proffered Presentations | Chairs: Peter Hoskin & Gerry Lowe |
|
| 11:25 |
Work of the National HDR Prostate Proknow Group | Katie McHugh Southend Hospital |
| 11.35 | Implementation of an altitude correction factor for low-energy brachytherapy seed measurements | Joe Hobson Royal Surrey Cancer Centre |
| 11.45 | Commissioning of a micro-silica bead TLD system for in vivo dosimetry and clinical feasibility study in patient undergoing prostate brachytherapy | Will Hamblyn & Amani Chowdhury Mount Vernon Cancer Centre |
| 11.55 | Dosimetric impact of a rectal spacer in HDR prostate brachytherapy: A retrospective paired analysis |
Samuel Worster |
| 12:05 | HDR brachytherapy boost with external beam radiotherapy for high-risk node-negative localised prostate cancer: long-term outcomes without systemic intensification & HDR brachytherapy boost with EBRT for localised prostate cancer: long-term outcomes and toxicity in predominately high-risk patients. | Mahbuba Choudhury Southend Hospital |
| 12:15 | Lunch/Exhibition and Poster Viewing | |
| Debate | ||
| 13:15 | Debate – “This House believes that brachytherapy provision should be centralised” | Mohammed Abdul‑Latif (Mount Vernon Cancer Centre) & Ann Henry (Leeds Teaching Hospital) |
| Proffered Presentations | Chairs: Amani Chowdhury & Dalia Haider | |
| 14:00 | MR Fusion, AI contoured target boost prosate brachytherapy for LDR and Alpha DaRT therapy | Diane Whitney Cambridge University Hospital |
| 14:10 | Single Institute Audit of HDR Brachytherapy as Monotherapy (27Gy in 2 fractions) for Localised Prostate Cancer | Alexander Cain Mid & South Essex Hosptials |
| 14:20 | Focal salvage HDR brachytherapy for locally recurrent prostate cancer | Emma Bennion-Pedley St James’ University Hospital |
| 14:30 | Salvage HDR brachytherapy for isolated seminal vesicle recurrence following definitive treatment for prostate cancer | Tracy Lim Mount Vernon Cancer Centre |
| 14:40 | The LDR BURST Trial: Comparing the side effects of LDR Brachytherapy against Ultra-hypofractionated Radiotherapy using Spacer gel Treatment | William Hayhurst Royal Surrey County Hospital |
| Invited Speakers | Chairs: Roberto Alonzi & Tracy Lim |
|
| 14:50 | Palladium-103 in LDR Prostate Brachytherapy: Dosimetric Advantages and the Path to Focal Treatment | Peter F. Orio Dana Faber Cancer Institute |
| 15:50 | Tea & Coffee/Exhibition and Poster Viewing | |
| 16:20 | Prostate brachytherapy – An international perspective | Hathal Haddad University of Tübingen |
| 16:50 | Theatrical Trials and Tribulations | Albert Edwards Kent Oncology Centre |
| 17:20 | Meeting Close and Handover | Roberto Alonzi |
| Poster Pitches | |
| Assessment of Delivered Versus Planned D90 Ratios in LDR Prostate Brachytherapy | Chris Wood Edinburgh Cancer Centre |
| Is Post-Implant CT Dosimetry Necessary in the Era of Real-Time Planning? A Single-Centre Audit of LDR Prostate Brachytherapy | Niall Bergin SLRON |
| LDR brachytherapy (LDR) versus SABR for Low and Intermediate Risk Prostate Cancer | Khin Tun/Dr Ankit Chadha Mount Vernon Cancer Centre |
| Factors Influencing Overnight Hospital Stay Following LDR Prostate Brachytherapy: A Retrospective Study | Hanna Mahmood Mount Vernon Cancer Centre |
| A review of infection outcomes following HDR prostate brachytherapy at a single centre | Emma Stallard Mount Vernon Cancer Centre |
| Multi-Site Internal In-Vivo Dose Verification in HDR Prostate Brachytherapy: Clinical Implementation of a Novel Dosimetry System | Fatemeh Nazari TRUEInvivo |
| Patient experience of HDR Prostate Brachytherapy at Mount Vernon Cancer Centre (RTT) | Kerry Chapman Mount Vernon Cancer Centre |
| Service Evaluation of Corrective Action in HDR Prostate Brachytherapy: Establishing Tolerance Thresholds Following a Near Miss Incident | Thomas Hague Mount Vernon Cancer Centre |
| Plan2Plan – Using ESAPI to Automate the Plan-Checking of Copied Brachytherapy Plans (Physics) | George Kirby Mount Vernon Cancer Centre |
| Utilisation of LDR Seeds using 4D Brachytherapy Technique | Matthew Bolt Royal Surrey Cancer Centre |
| Review of a New Dosimetry System in LDR Brachytherapy | Emma Doran Beatson West of Scotland Cancer Centre |
| Improving ergonomics and standardization of free needle length measurement in prostate HDR brachytherapy | Tomasz Kostecki University of Silesia, Katowice |
| Patient Reported Outcomes and Dosimetric Impact of Hydrogel Rectal Spacers in Prostate Radiotherapy | Sara Hodgkinson Kent Oncology Centre |